RxDoctor Payments Data

Chase Dukes, MD

Orthopaedic Surgery · Helena, MTNPI 1518205822

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (59.2%), education and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 77.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $22,952 and has fallen 93.0% since, to $1,607 in 2025. Among orthopaedic surgery clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,811in general payments, 2019–2025

Across 90 payments — averaging $375.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$26K
  • Zimmer Biomet$3K
  • Gemini Mountain Medical, LLC$2K
  • Stryker$1K
  • Medacta USA, Inc.$465
  • Smith+Nephew$176
  • plus $800 from 8 others

What the payments were for

  • Grants$20,00059%
  • Travel & lodging$3,31210%
  • Food & beverage$3,69911%
  • Education$6,80120%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,811 in reported general payments places this provider in the 90th percentile of 76 orthopaedic surgery providers in Montana.

See all orthopaedic surgery providers in Montana

Medicare billing

Part B allowed, 2024
$62,341
Medicare patients
172
Services billed
820

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naproxen27$87
Dexamethasone33$76
Ondansetron OdtOndansetron11$74
Cephalexin13$33
Meloxicam17$17

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Helena

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →